Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities

If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

For Pivot Assistance

Please review the information provided by SPA

Hilda Alajajian, Grant Resources Specialist is available to meet with individuals or groups for assistance in identifying funding

Phone: (802)656-1322

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Laura Gordon.

Limited Competition Funding

Please contact Edward North for information on applying for Limited Funding Opportunities. 

Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources

  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

Highlights: New & Updated

New and Updated
New Children’s Leukemia Research Association – Any doctor in the United States at the Ph.D. or MD level who is involved in research towards finding the causes and cure for leukemia may apply. Deadline is June 30, 2018.

New Alex's Lemonade Stand Foundation: Familial RUNX1 Grant Program - Provides up to $125,000 per year for seed funding of novel scientific approaches to investigating familial platelet disorder leading to acute myeloid leukemia (FPD/AML). Letter of Intent Due July 2, 2018.

New Damon Runyon Innovation Award - The Damon Runyon-Rachleff Innovation Award provides support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis and treatment of cancer. This award is specifically designed to provide funding for extraordinary early career researchers who have an innovative, new idea but lack sufficient preliminary data to obtain traditional funding. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Deadline is July 6, 2018.

New Damon Runyon Fellowship Award– The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. Damon Runyon Postdoctoral Research Fellowships are granted for a four-year term with second-, third- and fourth- year funding contingent upon satisfactory progress reports. Fellows in their first and third years of funding will attend Damon Runyon Fellows' Retreats designed to foster collaboration and interaction between scientists working in different fields relevant to cancer. Deadline is August 15, 2018.

New AACR - Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research 

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves. Nominations must be submitted online at by 4 p.m. U.S. ET on Wednesday, September 5, 2018.

New AACR - Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research  This award will recognize a worthy cancer researcher who has conducted highly meritorious translational and
clinical cancer research anywhere in the world. The award will honor an outstanding researcher who has not yet reached 51 years of age at the time of the award presentation.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves. Nominations must be submitted online at by 4 p.m. U.S. ET on Wednesday, September 5, 2018.
New Award for Outstanding Achievement in Chemistry in Cancer Research – The award will be given for outstanding, novel and significant chemistry research, which has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, the prevention of cancer or the treatment of patients with cancer. Such research may include, but is not limited to, drug discovery & design; structural biology; proteomics, metabolomics & biological mass spectrometry; chemical aspects of carcinogenesis; imaging agents & radiotherapeutics; & chemical biology. Deadline is September 12, 2018.
New Improving the Reach and Quality of Cancer Care in Rural Populations – The purpose of the administrative supplement is to provide sis Funding Opportunity is to reduce the burden of cancer and improve the quality of cancer care in rural areas among low-income and/or underserved populations. Deadline is September 19, 2018.

New Young-Onset Colorectal Cancer Grant- The Colon Cancer Alliance Chris4 Life Research Grants in Young-Onset Colorectal Cancer Research represent an effort to encourage and support researchers to conduct young-onset colorectal cancer research and to establish a successful career path in this field. The research proposed for funding may be as follows: basic, translational, clinical, or epidemiological in nature; and should focus on changes in the microbiome and its impact in the development of young onset colorectal cancer. Deadline is October 1, 2018.